{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T09:11:54Z","timestamp":1791277914715,"version":"4.1.0"},"reference-count":61,"publisher":"Spandidos Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.3892\/or.2016.4945","type":"journal-article","created":{"date-parts":[[2016,7,18]],"date-time":"2016-07-18T09:38:17Z","timestamp":1468834697000},"page":"1258-1268","source":"Crossref","is-referenced-by-count":9,"title":["Proteomic analysis of imatinib-resistant CML-T1 cells reveals calcium homeostasis as a potential therapeutic target"],"prefix":"10.3892","volume":"36","author":[{"given":"O.","family":"Toman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Kabickova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Vit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Fiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. Machova","family":"Polakova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Zach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Linhartova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Vyoral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Petrak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2016,7,18]]},"reference":[{"key":"key20180107221048_b1-or-36-03-1258","first-page":"85","article-title":"Chromosome studies on normal and leukemic human leukocytes","volume":"25","author":"Nowell","year":"1960","journal-title":"J Natl Cancer Inst"},{"key":"key20180107221048_b2-or-36-03-1258","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1126\/science.2408149","article-title":"Tyrosine kinase activity and transformation potency of bcr-abl oncogene products","volume":"247","author":"Lugo","year":"1990","journal-title":"Science"},{"key":"key20180107221048_b3-or-36-03-1258","first-page":"2049","article-title":"BCR-ABL tyrosine kinase activity regulates the expression of multiple genes implicated in the pathogenesis of chronic myeloid leukemia","volume":"60","author":"Deininger","year":"2000","journal-title":"Cancer Res"},{"key":"key20180107221048_b4-or-36-03-1258","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1177\/107327480901600202","article-title":"Signaling networks associated with BCR-ABL-dependent transformation","volume":"16","author":"Hazlehurst","year":"2009","journal-title":"Cancer Control"},{"key":"key20180107221048_b5-or-36-03-1258","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-642-54490-3_1","article-title":"Imatinib mesylate","volume":"201","author":"Waller","year":"2014","journal-title":"Recent Results Cancer Res"},{"key":"key20180107221048_b6-or-36-03-1258","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1182\/blood.V100.3.1014","article-title":"Several types of mutations of the Abl gene can be found in chronic myeloid leukemia patients resistant to STI571, and they can pre-exist to the onset of treatment","volume":"100","author":"Roche-Lestienne","year":"2002","journal-title":"Blood"},{"key":"key20180107221048_b7-or-36-03-1258","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1182\/blood-2002-05-1451","article-title":"Dose escalation of imatinib mesylate can overcome resistance to standard-dose therapy in patients with chronic myelogenous leukemia","volume":"101","author":"Kantarjian","year":"2003","journal-title":"Blood"},{"key":"key20180107221048_b8-or-36-03-1258","doi-asserted-by":"crossref","first-page":"114","DOI":"10.18553\/jmcsp.2015.21.2.114","article-title":"Emergence of BCR-ABL kinase domain mutations associated with newly diagnosed chronic myeloid leukemia: A meta-analysis of clinical trials of tyrosine kinase inhibitors","volume":"21","author":"Ursan","year":"2015","journal-title":"J Manag Care Spec Pharm"},{"key":"key20180107221048_b9-or-36-03-1258","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0165-4608(02)00615-5","article-title":"BCR\/ABL amplification in chronic myelocytic leukemia blast crisis following imatinib mesylate administration","volume":"139","author":"Campbell","year":"2002","journal-title":"Cancer Genet Cytogenet"},{"key":"key20180107221048_b10-or-36-03-1258","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.cancergencyto.2007.09.014","article-title":"Amplification of BCR-ABL and t(3;21) in a patient with blast crisis of chronic myelogenous leukemia","volume":"180","author":"Phan","year":"2008","journal-title":"Cancer Genet Cytogenet"},{"key":"key20180107221048_b11-or-36-03-1258","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/sj.leu.2401429","article-title":"Therapeutic targeting of Src-kinase Lyn in myeloid leukemic cell growth","volume":"13","author":"Roginskaya","year":"1999","journal-title":"Leukemia"},{"key":"key20180107221048_b12-or-36-03-1258","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1756-8722-4-6","article-title":"BCR-ABL1-independent PI3Kinase activation causing imatinib-resistance","volume":"4","author":"Quentmeier","year":"2011","journal-title":"J Hematol Oncol"},{"key":"key20180107221048_b13-or-36-03-1258","doi-asserted-by":"crossref","first-page":"5006","DOI":"10.1002\/pmic.200900335","article-title":"Identification of molecular targets for selective elimination of TRAIL-resistant leukemia cells. From spots to in vitro assays using TOP15 charts","volume":"9","author":"Petrak","year":"2009","journal-title":"Proteomics"},{"key":"key20180107221048_b14-or-36-03-1258","doi-asserted-by":"crossref","first-page":"e0135314","DOI":"10.1371\/journal.pone.0135314","article-title":"Detailed functional and proteomic characterization of fludarabine resistance in mantle cell lymphoma cells","volume":"10","author":"Lorkova","year":"2015","journal-title":"PLoS One"},{"key":"key20180107221048_b15-or-36-03-1258","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/labinvest.2014.61","article-title":"Mouse models of mantle cell lymphoma, complex changes in gene expression and phenotype of engrafted MCL cells: Implications for preclinical research","volume":"94","author":"Klanova","year":"2014","journal-title":"Lab Invest"},{"key":"key20180107221048_b16-or-36-03-1258","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.exphem.2009.10.003","article-title":"Constant BCR-ABL transcript level \u22650.1% (IS) in patients with CML responding to imatinib with complete cytogenetic remission may indicate mutation analysis","volume":"38","author":"Pol\u00e1kov\u00e1","year":"2010","journal-title":"Exp Hematol"},{"key":"key20180107221048_b17-or-36-03-1258","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1007\/s00432-014-1845-6","article-title":"Next-generation deep sequencing improves detection of BCR-ABL1 kinase domain mutations emerging under tyrosine kinase inhibitor treatment of chronic myeloid leukemia patients in chronic phase","volume":"141","author":"Machova Polakova","year":"2015","journal-title":"J Cancer Res Clin Oncol"},{"key":"key20180107221048_b18-or-36-03-1258","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1471-4159.2011.07194.x","article-title":"Cytosolic zinc release and clearance in hippocampal neurons exposed to glutamate - the role of pH and sodium","volume":"117","author":"Kiedrowski","year":"2011","journal-title":"J Neurochem"},{"key":"key20180107221048_b19-or-36-03-1258","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0022-3565(24)36684-4","article-title":"The human thromboxane A2 receptor \u03b1 isoform (TP\u03b1) functionally couples to the G proteins Gq and G11 in vivo and is activated by the isoprostane 8-epi prostaglandin F2\u03b1","volume":"281","author":"Kinsella","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"key20180107221048_b20-or-36-03-1258","doi-asserted-by":"crossref","first-page":"3440","DOI":"10.1016\/S0021-9258(19)83641-4","article-title":"A new generation of Ca2+ indicators with greatly improved fluorescence properties","volume":"260","author":"Grynkiewicz","year":"1985","journal-title":"J Biol Chem"},{"key":"key20180107221048_b21-or-36-03-1258","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/leu.2014.217","article-title":"A certified plasmid reference material for the standardisation of BCR-ABL1 mRNA quantification by real-time quantitative PCR","volume":"29","author":"White","year":"2015","journal-title":"Leukemia"},{"key":"key20180107221048_b22-or-36-03-1258","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212\u0394\u0394Ct method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"key20180107221048_b23-or-36-03-1258","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1182\/blood.V74.4.1381.1381","article-title":"CML-T1: A cell line derived from T-lymphocyte acute phase of chronic myelogenous leukemia","volume":"74","author":"Kuriyama","year":"1989","journal-title":"Blood"},{"key":"key20180107221048_b24-or-36-03-1258","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/0145-2126(94)90103-1","article-title":"Leukemia cell lines: In vitro models for the study of chronic myeloid leukemia","volume":"18","author":"Drexler","year":"1994","journal-title":"Leuk Res"},{"key":"key20180107221048_b25-or-36-03-1258","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1038\/sj.leu.2402741","article-title":"Molecular and chromosomal mechanisms of resistance to imatinib (STI571) therapy","volume":"16","author":"Hochhaus","year":"2002","journal-title":"Leukemia"},{"key":"key20180107221048_b26-or-36-03-1258","doi-asserted-by":"crossref","first-page":"3472","DOI":"10.1182\/blood.V99.9.3472","article-title":"High frequency of point mutations clustered within the adenosine triphosphate-binding region of BCR\/ABL in patients with chronic myeloid leukemia or Ph-positive acute lymphoblastic leukemia who develop imatinib (STI571) resistance","volume":"99","author":"Branford","year":"2002","journal-title":"Blood"},{"key":"key20180107221048_b27-or-36-03-1258","doi-asserted-by":"crossref","first-page":"3442","DOI":"10.1158\/1078-0432.CCR-08-3291","article-title":"Abnormalities in glucose uptake and metabolism in imatinib-resistant human BCR-ABL-positive cells","volume":"15","author":"Kominsky","year":"2009","journal-title":"Clin Cancer Res"},{"key":"key20180107221048_b28-or-36-03-1258","doi-asserted-by":"crossref","first-page":"735","DOI":"10.2174\/15680096113139990083","article-title":"Alternative splicing in chronic myeloid leukemia (CML): A novel therapeutic target?","volume":"13","author":"Adamia","year":"2013","journal-title":"Curr Cancer Drug Targets"},{"key":"key20180107221048_b29-or-36-03-1258","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1083\/jcb.139.1.169","article-title":"Identification of EBP50: A PDZ-containing phosphoprotein that associates with members of the ezrin-radixin-moesin family","volume":"139","author":"Reczek","year":"1997","journal-title":"J Cell Biol"},{"key":"key20180107221048_b30-or-36-03-1258","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1124\/pr.110.004176","article-title":"Regulation of G protein-coupled receptor function by Na+\/H+ exchange regulatory factors","volume":"63","author":"Ardura","year":"2011","journal-title":"Pharmacol Rev"},{"key":"key20180107221048_b31-or-36-03-1258","doi-asserted-by":"crossref","first-page":"19299","DOI":"10.1074\/jbc.M109.096081","article-title":"NHERF-1 binds to Mrp2 and regulates hepatic Mrp2 expression and function","volume":"285","author":"Li","year":"2010","journal-title":"J Biol Chem"},{"key":"key20180107221048_b32-or-36-03-1258","doi-asserted-by":"crossref","first-page":"238080","DOI":"10.1155\/2010\/238080","article-title":"Mechanisms of the regulation of the intestinal Na+\/H+ exchanger NHE3","volume":"2010","author":"He","year":"2010","journal-title":"J Biomed Biotechnol"},{"key":"key20180107221048_b33-or-36-03-1258","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/jcp.20057","article-title":"TRPC5 activation kinetics are modulated by the scaffolding protein ezrin\/radixin\/moesin-binding phosphoprotein-50 (EBP50)","volume":"201","author":"Obukhov","year":"2004","journal-title":"J Cell Physiol"},{"key":"key20180107221048_b34-or-36-03-1258","doi-asserted-by":"crossref","first-page":"37559","DOI":"10.1074\/jbc.M006635200","article-title":"Association of mammalian Trp4 and phospholipase C isozymes with a PDZ domain-containing protein, NHERF","volume":"275","author":"Tang","year":"2000","journal-title":"J Biol Chem"},{"key":"key20180107221048_b35-or-36-03-1258","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/onc.2010.389","article-title":"Direct interaction between NHERF1 and Frizzled regulates \u03b2-catenin signaling","volume":"30","author":"Wheeler","year":"2011","journal-title":"Oncogene"},{"key":"key20180107221048_b36-or-36-03-1258","doi-asserted-by":"crossref","first-page":"C727","DOI":"10.1152\/ajpcell.00011.2014","article-title":"Distribution dynamics and functional importance of NHERF1 in regulation of Mrp-2 trafficking in hepatocytes","volume":"307","author":"Karvar","year":"2014","journal-title":"Am J Physiol Cell Physiol"},{"key":"key20180107221048_b37-or-36-03-1258","first-page":"F37","article-title":"P-glycoprotein multidrug resistance and cancer","volume":"1288","author":"Bosch","year":"1996","journal-title":"Biochim Biophys Acta"},{"key":"key20180107221048_b38-or-36-03-1258","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0304-3835(96)04301-7","article-title":"Functional study of multidrug resistance with fluorescent dyes. Limits of the assay for low levels of resistance and application in clinical samples","volume":"106","author":"Canitrot","year":"1996","journal-title":"Cancer Lett"},{"key":"key20180107221048_b39-or-36-03-1258","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1113\/jphysiol.2005.090399","article-title":"NHERF family and NHE3 regulation","volume":"567","author":"Donowitz","year":"2005","journal-title":"J Physiol"},{"key":"key20180107221048_b40-or-36-03-1258","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.yjmcc.2013.04.008","article-title":"H+-activated Na+ influx in the ventricular myocyte couples Ca2+-signalling to intracellular pH","volume":"61","author":"Garciarena","year":"2013","journal-title":"J Mol Cell Cardiol"},{"key":"key20180107221048_b41-or-36-03-1258","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1182\/blood.V95.4.1427.004k48_1427_1434","article-title":"Apoptosis of leukemic cells accompanies reduction in intracellular pH after targeted inhibition of the Na+\/H+ exchanger","volume":"95","author":"Rich","year":"2000","journal-title":"Blood"},{"key":"key20180107221048_b42-or-36-03-1258","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1083\/jcb.148.5.857","article-title":"Reduced loading of intracellular Ca2+ stores and downregulation of capacitative Ca2+ influx in Bcl-2-overexpressing cells","volume":"148","author":"Pinton","year":"2000","journal-title":"J Cell Biol"},{"key":"key20180107221048_b43-or-36-03-1258","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1749-6632.2002.tb04744.x","article-title":"Cellular regulation of sodium-calcium exchange","volume":"976","author":"Condrescu","year":"2002","journal-title":"Ann NY Acad Sci"},{"key":"key20180107221048_b44-or-36-03-1258","doi-asserted-by":"crossref","first-page":"188","DOI":"10.2174\/187152907781745288","article-title":"Na+\/Ca2+ exchange inhibitors: A new class of calcium regulators","volume":"7","author":"Iwamoto","year":"2007","journal-title":"Cardiovasc Hematol Disord Drug Targets"},{"key":"key20180107221048_b45-or-36-03-1258","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1073\/pnas.87.7.2466","article-title":"Thapsigargin, a tumor promoter, discharges intracellular Ca2+ stores by specific inhibition of the endoplasmic reticulum Ca2+-ATPase","volume":"87","author":"Thastrup","year":"1990","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180107221048_b46-or-36-03-1258","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s10863-005-9472-1","article-title":"Studies of Ca2+ ATPase (SERCA) inhibition","volume":"37","author":"Inesi","year":"2005","journal-title":"J Bioenerg Biomembr"},{"key":"key20180107221048_b47-or-36-03-1258","doi-asserted-by":"crossref","first-page":"6229","DOI":"10.1016\/S0021-9258(18)50350-1","article-title":"The effect of ionomycin on calcium fluxes in sarcoplasmic reticulum vesicles and liposomes","volume":"254","author":"Beeler","year":"1979","journal-title":"J Biol Chem"},{"key":"key20180107221048_b48-or-36-03-1258","doi-asserted-by":"crossref","first-page":"443","DOI":"10.2174\/138161206775474503","article-title":"L-type calcium channels","volume":"12","author":"Triggle","year":"2006","journal-title":"Curr Pharm Des"},{"key":"key20180107221048_b49-or-36-03-1258","doi-asserted-by":"crossref","first-page":"10136","DOI":"10.1016\/S0021-9258(18)99200-8","article-title":"The inhibition of receptor-mediated and voltage-dependent calcium entry by the antiproliferative L-651,582","volume":"266","author":"Hupe","year":"1991","journal-title":"J Biol Chem"},{"key":"key20180107221048_b50-or-36-03-1258","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/jcp.21290","article-title":"Effects of carboxyamidotriazole on in vitro models of imatinib-resistant chronic myeloid leukemia","volume":"215","author":"Alessandro","year":"2008","journal-title":"J Cell Physiol"},{"key":"key20180107221048_b51-or-36-03-1258","first-page":"2869","article-title":"Carboxyamido-triazole (CAI), a signal transduction inhibitor induces growth inhibition and apoptosis in bladder cancer cells by modulation of Bcl-2","volume":"24","author":"Perabo","year":"2004","journal-title":"Anticancer Res"},{"key":"key20180107221048_b52-or-36-03-1258","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1124\/jpet.107.131888","article-title":"Anti-inflammatory and analgesic potency of carboxy-amidotriazole, a tumorostatic agent","volume":"325","author":"Guo","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"key20180107221048_b53-or-36-03-1258","doi-asserted-by":"crossref","first-page":"673","DOI":"10.2174\/0929867003374778","article-title":"The impact of immunosuppressive drugs on the analysis of T cell activation","volume":"7","author":"Rovira","year":"2000","journal-title":"Curr Med Chem"},{"key":"key20180107221048_b54-or-36-03-1258","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1002\/cyto.a.22401","article-title":"Nuclear translocation of nuclear factor of activated T cells (NFAT) as a quantitative pharmacodynamic parameter for tacrolimus","volume":"83","author":"Maguire","year":"2013","journal-title":"Cytometry A"},{"key":"key20180107221048_b55-or-36-03-1258","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/aps.2013.64","article-title":"Stem cell signaling as a target for novel drug discovery: Recent progress in the WNT and Hedgehog pathways","volume":"34","author":"An","year":"2013","journal-title":"Acta Pharmacol Sin"},{"key":"key20180107221048_b56-or-36-03-1258","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ccr.2010.04.025","article-title":"Wnt\/Ca2+\/NFAT signaling maintains survival of Ph+ leukemia cells upon inhibition of Bcr-Abl","volume":"18","author":"Gregory","year":"2010","journal-title":"Cancer Cell"},{"key":"key20180107221048_b57-or-36-03-1258","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.bbrc.2015.02.004","article-title":"Ca2+ homeostasis and endoplasmic reticulum (ER) stress: An integrated view of calcium signaling","volume":"460","author":"Krebs","year":"2015","journal-title":"Biochem Biophys Res Commun"},{"key":"key20180107221048_b58-or-36-03-1258","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1042\/bj20020431","article-title":"The inhibition of the sarcoplasmic\/endoplasmic reticulum Ca2+-ATPase by macrocyclic lactones and cyclosporin A","volume":"366","author":"Bilmen","year":"2002","journal-title":"Biochem J"},{"key":"key20180107221048_b59-or-36-03-1258","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.tcm.2004.06.003","article-title":"Regulation of ryanodine receptors by FK506 binding proteins","volume":"14","author":"Chelu","year":"2004","journal-title":"Trends Cardiovasc Med"},{"key":"key20180107221048_b60-or-36-03-1258","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1182\/blood.V101.6.2368","article-title":"MDR1 gene overexpression confers resistance to imatinib mesylate in leukemia cell line models","volume":"101","author":"Mahon","year":"2003","journal-title":"Blood"},{"key":"key20180107221048_b61-or-36-03-1258","doi-asserted-by":"crossref","first-page":"861","DOI":"10.2174\/138945006777709593","article-title":"Pharmacological strategies for overcoming multidrug resistance","volume":"7","author":"Nobili","year":"2006","journal-title":"Curr Drug Targets"}],"container-title":["Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/or.2016.4945\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T01:55:14Z","timestamp":1749002114000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/or.2016.4945"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,18]]},"references-count":61,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2016,7,18]]},"published-print":{"date-parts":[[2016,9]]}},"alternative-id":["10.3892\/or.2016.4945"],"URL":"https:\/\/doi.org\/10.3892\/or.2016.4945","relation":{},"ISSN":["1021-335X","1791-2431"],"issn-type":[{"value":"1021-335X","type":"print"},{"value":"1791-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,18]]}}}